$TEVA

2022 Q3 Form 10-Q Financial Statement

#000119312522276883 Filed on November 03, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2021 Q3
Revenue $3.595B $3.887B
YoY Change -7.51% -2.29%
Cost Of Revenue $1.926B $1.989B
YoY Change -3.17% -6.53%
Gross Profit $1.669B $1.898B
YoY Change -12.07% 2.59%
Gross Profit Margin 46.43% 48.83%
Selling, General & Admin $822.0M $864.0M
YoY Change -4.86% 1.29%
% of Gross Profit 49.25% 45.52%
Research & Development $175.0M $222.0M
YoY Change -21.17% -6.72%
% of Gross Profit 10.49% 11.7%
Depreciation & Amortization $321.0M $329.0M
YoY Change -2.43% -13.65%
% of Gross Profit 19.23% 17.33%
Operating Expenses $997.0M $1.092B
YoY Change -8.7% -2.06%
Operating Profit $419.0M $806.0M
YoY Change -48.01% 9.66%
Interest Expense -$230.0M -$254.0M
YoY Change -9.45% 22.12%
% of Operating Profit -54.89% -31.51%
Other Income/Expense, Net -$252.0M $13.00M
YoY Change -2038.46% -85.71%
Pretax Income $166.0M $382.0M
YoY Change -56.54% -108.57%
Income Tax $107.0M $76.00M
% Of Pretax Income 64.46% 19.9%
Net Earnings $56.00M $290.0M
YoY Change -80.69% -106.67%
Net Earnings / Revenue 1.56% 7.46%
Basic Earnings Per Share $0.05 $0.26
Diluted Earnings Per Share $0.05 $261.5K
COMMON SHARES
Basic Shares Outstanding 1.111B 1.103B
Diluted Shares Outstanding 1.119B 1.109B

Balance Sheet

Concept 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.225B $2.045B
YoY Change 8.8% 11.93%
Cash & Equivalents $2.225B $2.045B
Short-Term Investments
Other Short-Term Assets $579.0M $1.896B
YoY Change -69.46% 32.4%
Inventory $3.859B $4.167B
Prepaid Expenses $1.045B
Receivables $3.730B $4.046B
Other Receivables $0.00 $0.00
Total Short-Term Assets $11.45B $12.15B
YoY Change -5.77% -0.05%
LONG-TERM ASSETS
Property, Plant & Equipment $5.568B $6.547B
YoY Change -14.95% -2.41%
Goodwill $18.43B $20.18B
YoY Change -8.65% -0.24%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $438.0M $1.139B
YoY Change -61.55% -14.49%
Total Long-Term Assets $32.80B $35.70B
YoY Change -8.12% -5.0%
TOTAL ASSETS
Total Short-Term Assets $11.45B $12.15B
Total Long-Term Assets $32.80B $35.70B
Total Assets $44.25B $47.85B
YoY Change -7.52% -3.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.635B $1.514B
YoY Change 7.99% -11.77%
Accrued Expenses $2.537B $2.590B
YoY Change -2.05% 10.87%
Deferred Revenue
YoY Change
Short-Term Debt $23.00M $323.0M
YoY Change -92.88% -48.89%
Long-Term Debt Due $2.746B $2.386B
YoY Change 15.09% 61.87%
Total Short-Term Liabilities $11.53B $11.83B
YoY Change -2.46% -2.3%
LONG-TERM LIABILITIES
Long-Term Debt $18.50B $21.04B
YoY Change -12.07% -10.54%
Other Long-Term Liabilities $3.846B $2.628B
YoY Change 46.35% -0.94%
Total Long-Term Liabilities $23.20B $23.67B
YoY Change -1.96% -9.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.53B $11.83B
Total Long-Term Liabilities $23.20B $23.67B
Total Liabilities $34.73B $37.38B
YoY Change -7.09% -6.88%
SHAREHOLDERS EQUITY
Retained Earnings -$11.66B
YoY Change
Common Stock $57.00M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $4.128B
YoY Change
Treasury Stock Shares $106.0M
Shareholders Equity $8.767B $10.47B
YoY Change
Total Liabilities & Shareholders Equity $44.25B $47.85B
YoY Change -7.52% -3.79%

Cashflow Statement

Concept 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income $56.00M $290.0M
YoY Change -80.69% -106.67%
Depreciation, Depletion And Amortization $321.0M $329.0M
YoY Change -2.43% -13.65%
Cash From Operating Activities $544.0M $529.0M
YoY Change 2.84% 72.31%
INVESTING ACTIVITIES
Capital Expenditures -$122.0M -$146.0M
YoY Change -16.44% 2.1%
Acquisitions $0.00
YoY Change
Other Investing Activities $269.0M $434.0M
YoY Change -38.02% 44.67%
Cash From Investing Activities $147.0M $288.0M
YoY Change -48.96% 83.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $365.0M
YoY Change
Cash From Financing Activities -440.0M -1.177B
YoY Change -62.62% 11.35%
NET CHANGE
Cash From Operating Activities 544.0M 529.0M
Cash From Investing Activities 147.0M 288.0M
Cash From Financing Activities -440.0M -1.177B
Net Change In Cash 251.0M -360.0M
YoY Change -169.72% -39.29%
FREE CASH FLOW
Cash From Operating Activities $544.0M $529.0M
Capital Expenditures -$122.0M -$146.0M
Free Cash Flow $666.0M $675.0M
YoY Change -1.33% 50.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
L3
dei Entity Address Address Line1
EntityAddressAddressLine1
124 Dvora HaNevi’a St
dei Entity Address City Or Town
EntityAddressCityOrTown
Tel Aviv
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
6944020
dei City Area Code
CityAreaCode
3
CY2021Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
21617000000
dei Local Phone Number
LocalPhoneNumber
914-8213
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0000818686
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Security12b Title
Security12bTitle
American Depositary Shares, each representing one Ordinary Share
dei Trading Symbol
TradingSymbol
TEVA
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
354000000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
416000000
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1110644809
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2225000000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2165000000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
94000000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
90000000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3730000000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4529000000
CY2022Q3 us-gaap Inventory Net
InventoryNet
3859000000
CY2021Q4 us-gaap Inventory Net
InventoryNet
3818000000
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1045000000
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
23200000000
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
25395000000
teva Interest Rate Swap Loss
InterestRateSwapLoss
2000000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1075000000
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
579000000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
965000000
CY2022Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
16000000
CY2021Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
19000000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
11453000000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
12573000000
CY2022Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1546000000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
596000000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
438000000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
515000000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5568000000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5982000000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
422000000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
495000000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2578000000
CY2022Q3 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
18497000000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6393000000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7466000000
CY2022Q3 us-gaap Goodwill
Goodwill
18433000000
CY2021Q4 us-gaap Goodwill
Goodwill
20040000000
CY2022Q3 us-gaap Assets
Assets
44252000000
CY2021Q4 us-gaap Assets
Assets
47666000000
CY2022Q3 us-gaap Debt Current
DebtCurrent
2769000000
CY2021Q4 us-gaap Debt Current
DebtCurrent
1426000000
CY2022Q3 teva Sales Reserves And Allowances
SalesReservesAndAllowances
3648000000
CY2021Q4 teva Sales Reserves And Allowances
SalesReservesAndAllowances
4241000000
CY2022Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1635000000
CY2021Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1686000000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
496000000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
563000000
CY2022Q3 teva Accrued Expenses
AccruedExpenses
2041000000
CY2021Q4 teva Accrued Expenses
AccruedExpenses
2208000000
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
945000000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
903000000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
11534000000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11027000000
CY2022Q3 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
503000000
CY2021Q4 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
784000000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3846000000
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
dei Entity Address Country
EntityAddressCountry
IL
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-16174
dei Entity Registrant Name
EntityRegistrantName
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 us-gaap Liabilities
Liabilities
34734000000
CY2021Q4 us-gaap Liabilities
Liabilities
36422000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.1
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.1
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2495000000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2495000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1216000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1209000000
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
57000000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
57000000
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
27652000000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
27561000000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11660000000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10529000000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3153000000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2683000000
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
106000000
CY2022Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
106000000
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
4128000000
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
4128000000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
8767000000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10278000000
CY2022Q3 us-gaap Minority Interest
MinorityInterest
751000000
CY2021Q4 us-gaap Minority Interest
MinorityInterest
966000000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9519000000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11244000000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44252000000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47666000000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3595000000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3887000000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11041000000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11778000000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1926000000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2093000000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5839000000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6234000000
CY2022Q3 us-gaap Gross Profit
GrossProfit
1669000000
CY2021Q3 us-gaap Gross Profit
GrossProfit
1794000000
us-gaap Gross Profit
GrossProfit
5203000000
us-gaap Gross Profit
GrossProfit
5544000000
CY2022Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
175000000
CY2021Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
222000000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
628000000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
723000000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
539000000
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
597000000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1716000000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1798000000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
283000000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
291000000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
892000000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
822000000
CY2022Q3 teva Intangible Assets Impairments
IntangibleAssetsImpairments
24000000
CY2021Q3 teva Intangible Assets Impairments
IntangibleAssetsImpairments
21000000
teva Intangible Assets Impairments
IntangibleAssetsImpairments
223000000
teva Intangible Assets Impairments
IntangibleAssetsImpairments
295000000
CY2022Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
745000000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q3 teva Impairments Restructuring And Others
ImpairmentsRestructuringAndOthers
36000000
CY2021Q3 teva Impairments Restructuring And Others
ImpairmentsRestructuringAndOthers
62000000
teva Impairments Restructuring And Others
ImpairmentsRestructuringAndOthers
282000000
teva Impairments Restructuring And Others
ImpairmentsRestructuringAndOthers
227000000
CY2022Q3 teva Legal Settlements And Loss Contingencies
LegalSettlementsAndLossContingencies
195000000
CY2021Q3 teva Legal Settlements And Loss Contingencies
LegalSettlementsAndLossContingencies
3000000
teva Legal Settlements And Loss Contingencies
LegalSettlementsAndLossContingencies
2048000000
teva Legal Settlements And Loss Contingencies
LegalSettlementsAndLossContingencies
113000000
CY2022Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
2000000
CY2021Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
25000000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
88000000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
73000000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
419000000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
623000000
us-gaap Operating Income Loss
OperatingIncomeLoss
-1244000000
us-gaap Operating Income Loss
OperatingIncomeLoss
1638000000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-252000000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-241000000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-721000000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-805000000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
166000000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
382000000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1964000000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
833000000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
107000000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
76000000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-792000000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
235000000
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1000000
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5000000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
20000000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
9000000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
58000000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
302000000
us-gaap Profit Loss
ProfitLoss
-1152000000
us-gaap Profit Loss
ProfitLoss
608000000
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3000000
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
11000000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-21000000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
32000000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
56000000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
292000000
us-gaap Net Income Loss
NetIncomeLoss
-1132000000
us-gaap Net Income Loss
NetIncomeLoss
576000000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1111000000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1103000000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1109000000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1102000000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1119000000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1109000000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1109000000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1109000000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
58000000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
302000000
us-gaap Profit Loss
ProfitLoss
-1152000000
us-gaap Profit Loss
ProfitLoss
608000000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-402000000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-195000000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-684000000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-325000000
CY2022Q3 teva Unrealized Gain Loss On Derivative Net Of Tax
UnrealizedGainLossOnDerivativeNetOfTax
7000000
CY2021Q3 teva Unrealized Gain Loss On Derivative Net Of Tax
UnrealizedGainLossOnDerivativeNetOfTax
7000000
teva Unrealized Gain Loss On Derivative Net Of Tax
UnrealizedGainLossOnDerivativeNetOfTax
21000000
teva Unrealized Gain Loss On Derivative Net Of Tax
UnrealizedGainLossOnDerivativeNetOfTax
21000000
CY2022Q3 us-gaap Other Comprehensive Income Loss Finalization Of Pension And Non Pension Postretirement Plan Valuation Net Of Tax
OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
0
CY2021Q3 us-gaap Other Comprehensive Income Loss Finalization Of Pension And Non Pension Postretirement Plan Valuation Net Of Tax
OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
1000000
us-gaap Other Comprehensive Income Loss Finalization Of Pension And Non Pension Postretirement Plan Valuation Net Of Tax
OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
0
us-gaap Other Comprehensive Income Loss Finalization Of Pension And Non Pension Postretirement Plan Valuation Net Of Tax
OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
2000000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-395000000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-187000000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-663000000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-302000000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-337000000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
115000000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1815000000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
306000000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-40000000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-3000000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-214000000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-49000000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-297000000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
118000000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1601000000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
355000000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9828000000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
58000000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-395000000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26000000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9519000000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11311000000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
302000000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-187000000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26000000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11451000000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11244000000
us-gaap Profit Loss
ProfitLoss
-1152000000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-663000000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1000000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
88000000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9519000000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11061000000
us-gaap Profit Loss
ProfitLoss
608000000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-302000000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
86000000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11451000000
us-gaap Profit Loss
ProfitLoss
-1152000000
us-gaap Profit Loss
ProfitLoss
608000000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1002000000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1010000000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1002000000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
401000000
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-1007000000
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
1881000000
teva Deferred Income Taxes Net And Uncertain Tax Positions
DeferredIncomeTaxesNetAndUncertainTaxPositions
-1214000000
teva Deferred Income Taxes Net And Uncertain Tax Positions
DeferredIncomeTaxesNetAndUncertainTaxPositions
13000000
us-gaap Share Based Compensation
ShareBasedCompensation
88000000
us-gaap Share Based Compensation
ShareBasedCompensation
86000000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-117000000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-4000000
teva Profit From Sale Of Long Lived Assets And Investment
ProfitFromSaleOfLongLivedAssetsAndInvestment
-1000000
teva Profit From Sale Of Long Lived Assets And Investment
ProfitFromSaleOfLongLivedAssetsAndInvestment
-109000000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
617000000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
342000000
teva Proceeds From Beneficial Interest In Exchange For Securitized Trade Receivables
ProceedsFromBeneficialInterestInExchangeForSecuritizedTradeReceivables
854000000
teva Proceeds From Beneficial Interest In Exchange For Securitized Trade Receivables
ProceedsFromBeneficialInterestInExchangeForSecuritizedTradeReceivables
1278000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
406000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
409000000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
45000000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
269000000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
7000000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
4000000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
172000000
teva Payment To Acquire Marketable Securities And Other Assets
PaymentToAcquireMarketableSecuritiesAndOtherAssets
2000000
teva Payment To Acquire Marketable Securities And Other Assets
PaymentToAcquireMarketableSecuritiesAndOtherAssets
36000000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-3000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
488000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1277000000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
491000000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
500000000
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
200000000
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
661000000
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
1475000000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-115000000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-5000000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-776000000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1671000000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-269000000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-80000000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
60000000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-132000000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2198000000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2177000000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2258000000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2045000000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2225000000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2045000000
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
33000000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2258000000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2045000000
CY2022Q3 teva Beneficial Interest Obtained In Exchange For Securitized Trade Receivables
BeneficialInterestObtainedInExchangeForSecuritizedTradeReceivables
883000000
CY2021Q3 teva Beneficial Interest Obtained In Exchange For Securitized Trade Receivables
BeneficialInterestObtainedInExchangeForSecuritizedTradeReceivables
1310000000
CY2022Q3 us-gaap Disposal Group Including Discontinued Operation Inventory Current
DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
0
CY2021Q4 us-gaap Disposal Group Including Discontinued Operation Inventory Current
DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
2000000
CY2022Q3 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment Current
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent
46000000
CY2021Q4 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment Current
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent
86000000
CY2022Q3 us-gaap Disposal Group Including Discontinued Operation Goodwill Current
DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent
0
CY2021Q4 us-gaap Disposal Group Including Discontinued Operation Goodwill Current
DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent
7000000
us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
-30000000
CY2021 us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
-76000000
CY2022Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
16000000
CY2021Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
19000000
CY2022Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
0
CY2021Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
43000000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3595000000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3887000000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11041000000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11778000000
CY2021Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
4309000000
teva Valuation Allowances And Reserves Related To Current Period Sales
ValuationAllowancesAndReservesRelatedToCurrentPeriodSales
9886000000
teva Valuation Allowances And Reserves Related To Prior Period Sales
ValuationAllowancesAndReservesRelatedToPriorPeriodSales
-158000000
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
10231000000
teva Valuation Allowances And Reserves Foreign Currency Translation
ValuationAllowancesAndReservesForeignCurrencyTranslation
-106000000
CY2022Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
3700000000
CY2020Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
4904000000
teva Valuation Allowances And Reserves Related To Current Period Sales
ValuationAllowancesAndReservesRelatedToCurrentPeriodSales
10364000000
teva Valuation Allowances And Reserves Related To Prior Period Sales
ValuationAllowancesAndReservesRelatedToPriorPeriodSales
-254000000
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
10669000000
teva Valuation Allowances And Reserves Foreign Currency Translation
ValuationAllowancesAndReservesForeignCurrencyTranslation
-37000000
CY2021Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
4308000000
CY2021Q4 us-gaap Goodwill
Goodwill
20040000000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
745000000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
12000000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
874000000
CY2022Q3 us-gaap Goodwill
Goodwill
18433000000
CY2022Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
26300000000
CY2021Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
25600000000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
745000000
CY2022Q3 us-gaap Reporting Unit Percentage Of Fair Value In Excess Of Carrying Amount
ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
0.09
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1964000000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
235000000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
833000000
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1801000000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1932000000
CY2022Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1292000000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1136000000
CY2022Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
606000000
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
587000000
CY2022Q3 us-gaap Other Inventory In Transit
OtherInventoryInTransit
160000000
CY2021Q4 us-gaap Other Inventory In Transit
OtherInventoryInTransit
163000000
CY2022Q3 us-gaap Inventory Net
InventoryNet
3859000000
CY2021Q4 us-gaap Inventory Net
InventoryNet
3818000000
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
18660000000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19982000000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12267000000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12516000000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6393000000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7466000000
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P10Y
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
165000000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
199000000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
576000000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
613000000
CY2022Q3 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
24000000
CY2021Q3 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
21000000
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
223000000
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
295000000
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
2746000000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1403000000
CY2022Q3 us-gaap Debt Current
DebtCurrent
2769000000
CY2021Q4 us-gaap Debt Current
DebtCurrent
1426000000
CY2022Q3 us-gaap Senior Notes
SeniorNotes
21322000000
CY2021Q4 us-gaap Senior Notes
SeniorNotes
23118000000
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
2746000000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1403000000
CY2022Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
81000000
CY2021Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
100000000
CY2022Q3 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
18497000000
CY2021Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
21617000000
CY2022Q3 teva Long Term Debt Currency Portion Usd
LongTermDebtCurrencyPortionUSD
0.65
CY2022Q3 teva Long Term Debt Currency Portion Eur
LongTermDebtCurrencyPortionEUR
0.33
CY2022Q3 teva Long Term Debt Currency Portion Chf
LongTermDebtCurrencyPortionCHF
0.02
CY2022Q3 teva Revenues Other Than Usd
RevenuesOtherThanUsd
0.47
us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
69000000
us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
29000000
us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
493000000
CY2022Q3 teva Forward Starting Interest Rate Swaps And Treasury Lock Agreements Losses
ForwardStartingInterestRateSwapsAndTreasuryLockAgreementsLosses
8000000
CY2021Q3 teva Forward Starting Interest Rate Swaps And Treasury Lock Agreements Losses
ForwardStartingInterestRateSwapsAndTreasuryLockAgreementsLosses
8000000
teva Forward Starting Interest Rate Swaps And Treasury Lock Agreements Losses
ForwardStartingInterestRateSwapsAndTreasuryLockAgreementsLosses
22000000
teva Forward Starting Interest Rate Swaps And Treasury Lock Agreements Losses
ForwardStartingInterestRateSwapsAndTreasuryLockAgreementsLosses
24000000
CY2022Q3 teva Interest Rate Swap Loss
InterestRateSwapLoss
1000000
CY2021Q3 teva Interest Rate Swap Loss
InterestRateSwapLoss
1000000
teva Interest Rate Swap Loss
InterestRateSwapLoss
3000000
CY2022Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
195000000
CY2021Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
3000000
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
2048000000
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
113000000
teva Restructuring Expense And Income
RestructuringExpenseAndIncome
The expense in the first nine months of 2021 was mainly due to the provision recorded for the carvedilol patent litigation.
CY2022Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
4077000000
CY2021Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
2710000000
CY2022Q3 teva Damages Assessment
DamagesAssessment
235500000
CY2021Q3 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
235500000
CY2022Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
60500000
teva Annual Sales Of Effexor
AnnualSalesOfEffexor
2600000000
CY2005Q1 teva Annual Sales Of Lamictal
AnnualSalesOfLamictal
950000000
CY2008Q3 teva Annual Sales Of Lamictal
AnnualSalesOfLamictal
2300000000
CY2013Q2 teva Annual Sales Of Niaspan
AnnualSalesOfNiaspan
416000000
CY2013Q3 teva Annual Sales Of Niaspan
AnnualSalesOfNiaspan
1100000000
CY2010Q4 teva Annual Sales Of Actos
AnnualSalesOfActos
3700000000
CY2010Q4 teva Annual Sales Of Actoplus
AnnualSalesOfActoplus
500000000
CY2012Q3 teva Annual Sales Of Actos
AnnualSalesOfActos
2800000000
CY2012Q3 teva Annual Sales Of Actoplus
AnnualSalesOfActoplus
430000000
CY2019 teva Annual Sales Of Sensipar
AnnualSalesOfSensipar
1400000000
CY2019Q3 teva Annual Sales At Time Of Settlement
AnnualSalesAtTimeOfSettlement
350000000
CY2020Q3 teva Annual Sales At Time Of Settlement
AnnualSalesAtTimeOfSettlement
700000000
CY2014 teva Annual Sales Of Copaxone
AnnualSalesOfCopaxone
373000000
CY2022Q3 teva Loss Contingency Claims Dismissed Value
LossContingencyClaimsDismissedValue
1000000
CY2022Q3 teva Percentage Of Wholesale Acquisition Cost Value In Cash In Lieu Of Product To Be Paid Under Settlement Agreement
PercentageOfWholesaleAcquisitionCostValueInCashInLieuOfProductToBePaidUnderSettlementAgreement
0.20
CY2022Q1 teva Percentage Of Population Of Subdivisions Will Formally Release As A Part Of Settlement
PercentageOfPopulationOfSubdivisionsWillFormallyReleaseAsAPartOfSettlement
96
CY2022Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
420000000
CY2022Q3 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
300000
CY2021Q3 teva Loss Contingencies On Environmental Laws Penalty
LossContingenciesOnEnvironmentalLawsPenalty
1400000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
107000000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
166000000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
76000000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
382000000
CY2022Q2 us-gaap Inventory Write Down
InventoryWriteDown
4200000000
CY2022Q2 teva Effective Income Tax Reconciliation Amount Inventory Written Off
EffectiveIncomeTaxReconciliationAmountInventoryWrittenOff
850000000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-792000000
teva Expected Impairment Of Income Tax Benefit
ExpectedImpairmentOfIncomeTaxBenefit
128000000
CY2022Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
4000000
CY2021Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
26000000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
34000000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
106000000
CY2022Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
6000000
CY2021Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
9000000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
100000000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-7000000
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
25000000
CY2021Q3 us-gaap Restructuring Charges
RestructuringCharges
28000000
us-gaap Restructuring Charges
RestructuringCharges
117000000
us-gaap Restructuring Charges
RestructuringCharges
96000000
CY2022Q3 teva Legal Settlements Loss Contingencies Impairments Other Expenses
LegalSettlementsLossContingenciesImpairmentsOtherExpenses
1000000
CY2021Q3 teva Legal Settlements Loss Contingencies Impairments Other Expenses
LegalSettlementsLossContingenciesImpairmentsOtherExpenses
-1000000
teva Legal Settlements Loss Contingencies Impairments Other Expenses
LegalSettlementsLossContingenciesImpairmentsOtherExpenses
31000000
teva Legal Settlements Loss Contingencies Impairments Other Expenses
LegalSettlementsLossContingenciesImpairmentsOtherExpenses
32000000
CY2022Q3 teva Impairment And Restructuring
ImpairmentAndRestructuring
36000000
CY2021Q3 teva Impairment And Restructuring
ImpairmentAndRestructuring
62000000
teva Impairment And Restructuring
ImpairmentAndRestructuring
282000000
teva Impairment And Restructuring
ImpairmentAndRestructuring
227000000
CY2022Q3 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
4000000
CY2021Q3 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
26000000
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
34000000
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
106000000
CY2022Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
6000000
CY2021Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
9000000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
100000000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-7000000
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
25000000
CY2021Q3 us-gaap Restructuring Charges
RestructuringCharges
28000000
us-gaap Restructuring Charges
RestructuringCharges
117000000
us-gaap Restructuring Charges
RestructuringCharges
96000000
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
25000000
CY2021Q3 us-gaap Restructuring Charges
RestructuringCharges
28000000
us-gaap Restructuring Charges
RestructuringCharges
117000000
us-gaap Restructuring Charges
RestructuringCharges
96000000
CY2021Q4 us-gaap Restructuring Reserve
RestructuringReserve
138000000
teva Restructuring Accrual Provision
RestructuringAccrualProvision
117000000
teva Utilization And Other
UtilizationAndOther
136000000
CY2022Q3 us-gaap Restructuring Reserve
RestructuringReserve
119000000
CY2020Q4 us-gaap Restructuring Reserve
RestructuringReserve
122000000
teva Restructuring Accrual Provision
RestructuringAccrualProvision
96000000
teva Utilization And Other
UtilizationAndOther
90000000
CY2021Q3 us-gaap Restructuring Reserve
RestructuringReserve
128000000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
90000000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1119000000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1109000000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1109000000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1109000000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2022Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
165000000
CY2021Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
199000000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
576000000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
613000000
CY2022Q3 teva Impairments Restructuring And Others
ImpairmentsRestructuringAndOthers
36000000
CY2021Q3 teva Impairments Restructuring And Others
ImpairmentsRestructuringAndOthers
62000000
teva Impairments Restructuring And Others
ImpairmentsRestructuringAndOthers
282000000
teva Impairments Restructuring And Others
ImpairmentsRestructuringAndOthers
227000000
CY2022Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
745000000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q3 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
24000000
CY2021Q3 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
21000000
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
223000000
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
295000000
CY2022Q3 teva Legal Settlements And Loss Contingencies
LegalSettlementsAndLossContingencies
195000000
CY2021Q3 teva Legal Settlements And Loss Contingencies
LegalSettlementsAndLossContingencies
3000000
teva Legal Settlements And Loss Contingencies
LegalSettlementsAndLossContingencies
2048000000
teva Legal Settlements And Loss Contingencies
LegalSettlementsAndLossContingencies
113000000
CY2022Q3 teva Other Unallocated Amounts
OtherUnallocatedAmounts
139000000
CY2021Q3 teva Other Unallocated Amounts
OtherUnallocatedAmounts
134000000
teva Other Unallocated Amounts
OtherUnallocatedAmounts
379000000
teva Other Unallocated Amounts
OtherUnallocatedAmounts
266000000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
419000000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
623000000
us-gaap Operating Income Loss
OperatingIncomeLoss
-1244000000
us-gaap Operating Income Loss
OperatingIncomeLoss
1638000000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-252000000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-241000000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-721000000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-805000000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
166000000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
382000000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1964000000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
833000000
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
33000000
CY2022Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
113000000
CY2022Q3 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
2201000000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
33000000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
176000000
CY2021Q4 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
2054000000
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
175000000
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
258000000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
-9000000
teva Bifurcated Embedded Derivatives
BifurcatedEmbeddedDerivatives
0
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
112000000
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
186000000
CY2022Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
18262000000
CY2021Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
22903000000

Files In Submission

Name View Source Status
0001193125-22-276883-index-headers.html Edgar Link pending
0001193125-22-276883-index.html Edgar Link pending
0001193125-22-276883.txt Edgar Link pending
0001193125-22-276883-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
d403730d10q.htm Edgar Link pending
d403730dex311.htm Edgar Link pending
d403730dex312.htm Edgar Link pending
d403730dex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
d403730d10q_htm.xml Edgar Link completed
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
teva-20220930.xsd Edgar Link pending
teva-20220930_cal.xml Edgar Link unprocessable
teva-20220930_def.xml Edgar Link unprocessable
teva-20220930_lab.xml Edgar Link unprocessable
teva-20220930_pre.xml Edgar Link unprocessable